| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: ERES |
| Security Type |
Common Stock |
| Lead Underwriter |
SG Cowen Securities Corp |
| Days In Registration |
337 |
| Date Filed |
29-Mar-2000 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Provide a business-to-business service of integrated software applications and technology consulting services to the pharmaceutical, biotechnology and medical device industries. We offer Internet and other technology-based |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| President and CEO |
Joseph A. Esposito |
| Number of Employees |
178 |
|
| Original Filing Information |
| US |
| Shares Filed |
4.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
600.0K |
| File Amount |
- |
| File Price Range |
$12.00 - $10.00 |
| File Mid Price |
$11.00 |
|
